Population Pharmacokinetics of Extended-Infusion Piperacillin-Tazobactam in Hospitalized Patients with Nosocomial Infections
Open Access
- 1 August 2012
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 56 (8), 4087-4094
- https://doi.org/10.1128/aac.00521-12
Abstract
While extended infusions of piperacillin-tazobactam (TZP) are increasingly used in practice, the effect of infusion on the pharmacokinetic (PK) profile of TZP has not been widely assessed. To assess its effect on the pharmacokinetic profile of TZP, seven serum samples were collected from 11 hospitalized patients who received 3.375 g TZP intravenously for 4 h every 8 h. Population pharmacokinetic models were fit to the PK data utilizing first-order, Michaelis-Menten (MM), and parallel first-order/MM clearance. A population PK model with first-order clearance was fit to the tazobactam PK data. Monte Carlo simulations (MCSs) were used to determine the most effective administration schedule to ensure that free piperacillin concentrations were above the MIC for at least 50% of the dosing interval (50% f T>MIC) and to quantify the extent of the nonlinear clearance. The model incorporating parallel linear/MM clearance best fit the piperacillin PK data. The MCSs demonstrated that approximately 50% of the administered piperacillin is cleared by the nonlinear clearance mechanism. The results of the MCSs also revealed that more intensive TZP extended infusion dosing schemes (3.375 to 4.5 g intravenously [3-h infusion] every 6 h) than those commonly used in clinical practice were needed to maximize the 50% f T>MIC for MICs of ≥8 mg/liter. This study suggests that extended infusion of TZP is the most effective method of administration for patients with nosocomial infections. Due to the hyperclearance nature of the hospitalized patient populations studied, more intensive TZP dosing regimens may be needed to maximize f T>MIC in certain hospitalized populations.This publication has 26 references indexed in Scilit:
- Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumoniaEuropean Respiratory Journal, 2010
- Nonlinear pharmacokinetics of piperacillin in healthy volunteers – implications for optimal dosage regimensBritish Journal of Clinical Pharmacology, 2010
- First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsisInternational Journal of Antimicrobial Agents, 2010
- Pharmacokinetic issues for antibiotics in the critically ill patientCritical Care Medicine, 2009
- Mortality at Low and High Estimated Glomerular Filtration Rate Values: A ‘U’ Shaped CurveNephron Clinical Practice, 2008
- Systematic Comparison of the Population Pharmacokinetics and Pharmacodynamics of Piperacillin in Cystic Fibrosis Patients and Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2007
- Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'Nature Reviews Microbiology, 2004
- Optimal Sampling Schedule Design for Populations of PatientsAntimicrobial Agents and Chemotherapy, 2003
- Dose Dependence of Piperacillin PharmacokineticsChemotherapy, 1982
- A program package for simulation and parameter estimation in pharmacokinetic systemsComputer Programs in Biomedicine, 1979